As of March 2017, an estimated 32 new products1 with the potential to treat or prevent serious bacterial infections are in clinical development. Below is a snapshot of the current nontraditional products pipeline, based on publicly available information and informed by external experts. It is updated periodically, as products advance or are known to drop out of development. Because this list is updated periodically, endnote numbers may not be sequential.
Please contact firstname.lastname@example.org with additions or updates.
March 2017 (PDF)